Literature DB >> 8263515

Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate.

I Westergren1, B Nyström, A Hamberger, C Nordborg, B B Johansson.   

Abstract

This article evaluates the influence of an opening of the blood-brain barrier (BBB) on compounds in brain extracellular fluid. The concentrations of amino acids and some other primary amines were determined in dialysates sampled from the right parietal cortex of rats before and after an intracarotid infusion of protamine sulfate. Extravasated plasma proteins were visualized by Evans blue/albumin and immunohistochemistry. CSF albumin--an indicator of blood-CSF barrier opening--was quantified with immunoelectrophoresis. The brains were macroscopically edematous after 10 mg but not after 5 mg of protamine sulfate. The higher dose led to a 50% death rate. The concentrations of amino acids did not change 10 min after the BBB opening. No significant alterations in the amino acid concentrations were observed after the lower dose. The concentrations of glutamate, aspartate, GABA, glycine, taurine, and phosphoethanolamine increased significantly within 50-80 min after the infusion of 10 mg of protamine sulfate. CSF albumin levels were significantly increased 1 h after infusion. We conclude that a dysfunction of the BBB, of a degree known to induce brain edema (10 mg of protamine sulfate), significantly increases the extracellular concentration of excitatory amino acids, GABA, taurine, and phosphoethanolamine in the extracellular space.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8263515     DOI: 10.1046/j.1471-4159.1994.62010159.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  Acute depression of energy metabolism after microdialysis probe implantation is distinct from ischemia-induced changes in mouse brain.

Authors:  Rachita K Sumbria; Jochen Klein; Ulrich Bickel
Journal:  Neurochem Res       Date:  2010-09-28       Impact factor: 3.996

3.  Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.

Authors:  Portia A Kunz; Alain C Burette; Richard J Weinberg; Benjamin D Philpot
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

Review 4.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

Review 5.  Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons.

Authors:  J N Kew; J G Richards; V Mutel; J A Kemp
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

6.  Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice.

Authors:  Marzia Martina; Marie-Eve B-Turcotte; Samantha Halman; Guochuan Tsai; Mario Tiberi; Joseph T Coyle; Richard Bergeron
Journal:  J Physiol       Date:  2005-01-20       Impact factor: 5.182

7.  Glycine induces bidirectional modifications in N-methyl-D-aspartate receptor-mediated synaptic responses in hippocampal CA1 neurons.

Authors:  Xiao-Yan Zhang; Fang Ji; Ning Wang; Lin-Lin Chen; Tian Tian; Wei Lu
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

8.  Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes.

Authors:  S Supplisson; C Bergman
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

9.  Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site.

Authors:  J N Kew; A Koester; J L Moreau; F Jenck; A M Ouagazzal; V Mutel; J G Richards; G Trube; G Fischer; A Montkowski; W Hundt; R K Reinscheid; M Pauly-Evers; J A Kemp; H Bluethmann
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

10.  Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.

Authors:  Alessandro Gozzi; Hugh Herdon; Adam Schwarz; Simone Bertani; Valerio Crestan; Giuliano Turrini; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.